Monitoring the bcr/abl fusion gene by RT-nested-PCR can be used to evalute the efficacy of the therapy and detect the minimal residual disease(MRD).

• RT -nestedPCR方法检测bcr/abl融合基因可以作为临床诊断、判定预后的指标 ,适用于微小残留病变的监测